Bank Central Asia Tbk vs Kalbe Farma Tbk — how do they compare? Bank Central Asia Tbk trades at Rp6,250 (market cap 774.97T, 11.26M 24h volume), while Kalbe Farma Tbk trades at Rp805 (market cap 37.45T, 12.74M 24h volume). The key difference: Bank Central Asia Tbk is far larger — about 20.7× Kalbe Farma Tbk's market cap, and Kalbe Farma Tbk is more actively traded (12.74M versus 11.26M). Which is the better fit depends on your goals.
| BBCA | KLBF | |
|---|---|---|
Market Cap | 774.97T | 37.45T |
Volume | 11.26M | 12.74M |
Lot | 112.56K | 127.45K |
Turnover | 71.01B | 10.21B |
Average Price | 6,308.48 | 801.16 |
Value | 71.01B | 10.21B |
Indicative Equilibrium Price | 6,350 | 805 |
Indicative Equilibrium Volume | 2.2M | 1.2K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Bank Central Asia, Tbk (the Company) was established under the name of N.V. Perseroan Dagang Dan Industrie Semarang Knitting Factory based on notarial deed No. 38 of Raden Mas Soeprapto dated 10 August 1955, which was then changed to PT Bank Central Asia based on notarial deed No. 144 of Ridwan Suselo dated 21 May 1974.
Read more on BBCA →PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →